Cytomos plans to revolutionise cell analysis by bringing understanding to production and intelligence to process automation to make cell therapies possible at scale.
Cytomos Dielectric Spectroscopy (CDS) is a proprietary and patented cell analysis technology spanning integrated sensors through to machine learning enhanced algorithms. It requires no interaction with cells under test, no expensive and time-consuming cell labelling, Cytomos provides benefits across the manufacturing industry underpinned by its uniquely scalable technology.
